# A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

> **NCT00629967** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 200 (actual)

## Conditions studied

- Chronic Hepatitis C
- Genotype

## Interventions

- **DRUG:** pegylated interferon alpha 2a and ribavirin
- **DRUG:** Pegylated interferon alfa-2a and ribavirin

## Key facts

- **NCT ID:** NCT00629967
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2008-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629967, "A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00629967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*